RecruitingNot ApplicableNCT05487274

TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion

Study Evaluating Reverse Versus Anatomic Total Shoulder Arthroplasty in Shoulders With Greater Than 15 Degrees of Retroversion in the Treatment of Osteoarthritis: Protocol


Sponsor

Ottawa Hospital Research Institute

Enrollment

108 participants

Start Date

Aug 9, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study will compare total shoulder arthroplasty (TSA) with an augmented glenoid component and reverse shoulder arthroplasty (RSA) procedures, in participants with advanced glenohumeral osteoarthritis aged 65 years and older, who also present with greater than 15 degrees of glenoid retroversion, in the context of a prospective, randomized controlled trial to determine the optimal treatment in this patient population.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Reverse Shoulder Arthroplasty and a procedure called Total Shoulder Arthroplasty + augmented glenoid component for people with osteoarthritis shoulder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETotal Shoulder Arthroplasty + augmented glenoid component

Replacement of the shoulder joint (ball and socket, or humeral head and glenoid) using prosthetic components. A prosthetic component is also implanted to correct for the amount of bone loss in the shoulder and restore stability.

PROCEDUREReverse Shoulder Arthroplasty

Replacement of the shoulder joint like the TSA, however the orientation of the ball and socket is reversed.


Locations(1)

Ottawa Hospital Research Institute

Ottawa, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05487274


Related Trials